{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:07:35Z","timestamp":1774084055444,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00428-019-02739-x","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T21:02:46Z","timestamp":1578949366000},"page":"499-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and M\u00fcllerian-type"],"prefix":"10.1007","volume":"476","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2697-114X","authenticated-orcid":false,"given":"Shiho","family":"Asaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Kugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risako","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Yazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"key":"2739_CR1","doi-asserted-by":"publisher","unstructured":"Smith HO, Tiffany MF, Qualls CR, Key CR (2000) The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States\u2014a 24-year population-based study. Gynecol Oncol 78(2):97\u2013105. https:\/\/doi.org\/10.1006\/gyno.2000.5826","DOI":"10.1006\/gyno.2000.5826"},{"key":"2739_CR2","doi-asserted-by":"publisher","unstructured":"Adegoke O, Kulasingam S, Virnig B (2012) Cervical cancer trends in the United States: a 35-year population-based analysis. J Women's Health 21(10):1031\u20131037. https:\/\/doi.org\/10.1089\/jwh.2011.3385","DOI":"10.1089\/jwh.2011.3385"},{"key":"2739_CR3","doi-asserted-by":"publisher","unstructured":"Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, Hakama M, Weiderpass E (2005) Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomark Prev 14(9):2191\u20132199. https:\/\/doi.org\/10.1158\/1055-9965.Epi-05-0231","DOI":"10.1158\/1055-9965.Epi-05-0231"},{"key":"2739_CR4","doi-asserted-by":"publisher","unstructured":"Pirog EC, Lloveras B, Molijn A, Tous S, Guimera N, Alejo M, Clavero O, Klaustermeier J, Jenkins D, Quint WG, Xavier Bosch F, Alemany L, de Sanjose S (2014) HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases. Mod Pathol 27(12):1559\u20131567. https:\/\/doi.org\/10.1038\/modpathol.2014.55","DOI":"10.1038\/modpathol.2014.55"},{"key":"2739_CR5","doi-asserted-by":"publisher","unstructured":"Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX (2006) Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 98(5):303\u2013315. https:\/\/doi.org\/10.1093\/jnci\/djj067","DOI":"10.1093\/jnci\/djj067"},{"key":"2739_CR6","doi-asserted-by":"publisher","unstructured":"Karamurzin YS, Kiyokawa T, Parkash V, Jotwani AR, Patel P, Pike MC, Soslow RA, Park KJ (2015) Gastric-type endocervical adenocarcinoma an aggressive tumor with unusual metastatic patterns and poor prognosis. Am J Surg Pathol 39(11):1449\u20131457. https:\/\/doi.org\/10.1097\/pas.0000000000000532","DOI":"10.1097\/pas.0000000000000532"},{"key":"2739_CR7","doi-asserted-by":"publisher","unstructured":"Kusanagi Y, Kojima A, Mikami Y, Kiyokawa T, Sudo T, Yamaguchi S, Nishimura R (2010) Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype. Am J Pathol 177(5):2169\u20132175. https:\/\/doi.org\/10.2353\/ajpath.2010.100323","DOI":"10.2353\/ajpath.2010.100323"},{"key":"2739_CR8","doi-asserted-by":"publisher","unstructured":"Kojima A, Mikami Y, Sudo T, Yamaguchi S, Kusanagi Y, Ito M, Nishimura R (2007) Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol 31(5):664\u2013672. https:\/\/doi.org\/10.1097\/01.pas.0000213434.91868.b0","DOI":"10.1097\/01.pas.0000213434.91868.b0"},{"key":"2739_CR9","doi-asserted-by":"publisher","unstructured":"Mikami Y, Kyokawa T, Hata S, Fujiwara K, Moriya T, Sasano H, Manabe T, Akahira JI, Ito K, Tase T, Yaegashi N, Sato I, Tateno H, Naganuma H (2004) Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia\/pyloric gland metaplasia and \u2018adenoma malignum\u2019. Mod Pathol 17(8):962\u2013972. https:\/\/doi.org\/10.1038\/modpathol.3800148","DOI":"10.1038\/modpathol.3800148"},{"issue":"8","key":"2739_CR10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/00000478-199908000-00005","volume":"23","author":"MR Nucci","year":"1999","unstructured":"Nucci MR, Clement PB, Young RH (1999) Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am J Surg Pathol 23(8):886\u2013891","journal-title":"Am J Surg Pathol"},{"key":"2739_CR11","doi-asserted-by":"publisher","unstructured":"Kawauchi S, Kusuda T, Liu XP, Suehiro Y, Kaku T, Mikami Y, Takeshita M, Nakao M, Chochi Y, Sasaki K (2008) Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma? A comparative molecular-genetic and immunohistochemical study. Am J Surg Pathol 32(12):1807\u20131815. https:\/\/doi.org\/10.1097\/PAS.0b013e3181883722","DOI":"10.1097\/PAS.0b013e3181883722"},{"key":"2739_CR12","unstructured":"Wilbur DC, Mikami Y, Colgan TJ, Park KJ, Ferenczy AS, Ronnett BM, Hirschowitz L, Schneider A, Loening T, Soslow R, McCluggage WG, Wells M, Wright T (2014) Glandular tumours and precursors. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH (eds) WHO classification of tumours of female reproductive organs, 4th edn. International Agency for Research on Cancer, Lyon, pp 183\u2013189"},{"key":"2739_CR13","doi-asserted-by":"publisher","unstructured":"Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA (2018) International endocervical adenocarcinoma criteria and classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol 42(2):214\u2013226. https:\/\/doi.org\/10.1097\/pas.0000000000000986","DOI":"10.1097\/pas.0000000000000986"},{"key":"2739_CR14","doi-asserted-by":"publisher","unstructured":"Hodgson A, Park KJ, Djordjevic B, B EH, Nucci MR, Oliva E, Stolnicu S, Xu B, Soslow RA, Parra-Herran C (2018) International endocervical adenocarcinoma criteria and classification: validation and interobserver reproducibility. Am J Surg Pathol 43(1):75\u201383. https:\/\/doi.org\/10.1097\/pas.0000000000001095","DOI":"10.1097\/pas.0000000000001095"},{"key":"2739_CR15","doi-asserted-by":"publisher","unstructured":"Stolnicu S, Barsan I, Hoang L, Patel P, Chiriboga L, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA (2018) Diagnostic algorithmic proposal based on comprehensive immunohistochemical evaluation of 297 invasive endocervical adenocarcinomas. Am J Surg Pathol 42(8):989\u20131000. https:\/\/doi.org\/10.1097\/pas.0000000000001090","DOI":"10.1097\/pas.0000000000001090"},{"key":"2739_CR16","doi-asserted-by":"publisher","unstructured":"Stolnicu S, Hoang L, Chiu D, Hanko-Bauer O, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Oliva E, Park KJ, Abu-Rustum NR, Soslow RA (2019) Clinical outcomes of HPV-associated and unassociated endocervical adenocarcinomas categorized by the international endocervical adenocarcinoma criteria and classification (IECC). Am J Surg Pathol 43(4):466\u2013474. https:\/\/doi.org\/10.1097\/pas.0000000000001224","DOI":"10.1097\/pas.0000000000001224"},{"key":"2739_CR17","doi-asserted-by":"publisher","unstructured":"Hodgson A, Olkhov-Mitsel E, Howitt BE, Nucci MR, Parra-Herran C (2019) International endocervical adenocarcinoma criteria and classification (IECC): correlation with adverse clinicopathological features and patient outcome. J Clin Pathol 72(5):347\u2013353. https:\/\/doi.org\/10.1136\/jclinpath-2018-205632","DOI":"10.1136\/jclinpath-2018-205632"},{"key":"2739_CR18","doi-asserted-by":"publisher","unstructured":"Asaka S, Nakajima T, Momose M, Miyamoto T, Uehara T, Ota H (2019) Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix. Virchows Arch 474(1):79\u201386. https:\/\/doi.org\/10.1007\/s00428-018-2469-z","DOI":"10.1007\/s00428-018-2469-z"},{"issue":"1","key":"2739_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1309\/AMUR-K5L3-M2DN-2DK5","volume":"115","author":"H Ota","year":"2001","unstructured":"Ota H, Hayama M, Nakayama J, Hidaka H, Honda T, Ishii K, Fukushima M, Uehara T, Kurihara M, Ishihara K, Hotta K, Katsuyama T (2001) Cell lineage specificity of newly raised monoclonal antibodies against gastric mucins in normal, metaplastic, and neoplastic human tissues and their application to pathology diagnosis. Am J Clin Pathol 115(1):69\u201379","journal-title":"Am J Clin Pathol"},{"key":"2739_CR20","doi-asserted-by":"publisher","unstructured":"Nakajima K, Ota H, Zhang MX, Sano K, Honda T, Ishii K, Nakayama J (2003) Expression of gastric gland mucous cell-type mucin in normal and neoplastic human tissues. J Histochem Cytochem 51(12):1689\u20131698. https:\/\/doi.org\/10.1177\/002215540305101213","DOI":"10.1177\/002215540305101213"},{"key":"2739_CR21","doi-asserted-by":"publisher","unstructured":"Shinozaki A, Ushiku T, Morikawa T, Hino R, Sakatani T, Uozaki H, Fukayama M (2009) Epstein-Barr virus-associated gastric carcinoma: a distinct carcinoma of gastric phenotype by claudin expression profiling. J Histochem Cytochem 57(8):775\u2013785. https:\/\/doi.org\/10.1369\/jhc.2009.953810","DOI":"10.1369\/jhc.2009.953810"},{"key":"2739_CR22","doi-asserted-by":"publisher","unstructured":"Tamura A, Yamazaki Y, Hayashi D, Suzuki K, Sentani K, Yasui W, Tsukita S (2012) Claudin-based paracellular proton barrier in the stomach. Ann N Y Acad Sci 1258:108\u2013114. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06570.x","DOI":"10.1111\/j.1749-6632.2012.06570.x"},{"key":"2739_CR23","doi-asserted-by":"publisher","unstructured":"Shinozaki A, Shibahara J, Noda N, Tanaka M, Aoki T, Kokudo N, Fukayama M (2011) Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma. Virchows Arch 459(1):73\u201380. https:\/\/doi.org\/10.1007\/s00428-011-1092-z","DOI":"10.1007\/s00428-011-1092-z"},{"key":"2739_CR24","doi-asserted-by":"publisher","unstructured":"Tanaka M, Shibahara J, Fukushima N, Shinozaki A, Umeda M, Ishikawa S, Kokudo N, Fukayama M (2011) Claudin-18 is an early-stage marker of pancreatic carcinogenesis. J Histochem Cytochem 59(10):942\u2013952. https:\/\/doi.org\/10.1369\/0022155411420569","DOI":"10.1369\/0022155411420569"},{"key":"2739_CR25","doi-asserted-by":"publisher","unstructured":"Halimi SA, Maeda D, Shinozaki-Ushiku A, Koso T, Matsusaka K, Tanaka M, Arimoto T, Oda K, Kawana K, Yano T, Fujii T, Fukayama M (2013) Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary. Histopathology 63(4):534\u2013544. https:\/\/doi.org\/10.1111\/his.12182","DOI":"10.1111\/his.12182"},{"key":"2739_CR26","unstructured":"Maeda D (2015) Utility of claudin-18 and p16 immunohistochemistry for distinguishing gastric-type adenocarcinoma from other subtypes of cervical adenocarcinoma. Mod Pathol 28:296A\u2013297A"},{"key":"2739_CR27","doi-asserted-by":"publisher","unstructured":"Ordonez NG (2014) Cadherin 17 is a novel diagnostic marker for adenocarcinomas of the digestive system. Adv Anat Pathol 21(2):131\u2013137. https:\/\/doi.org\/10.1097\/pap.0000000000000008","DOI":"10.1097\/pap.0000000000000008"},{"key":"2739_CR28","doi-asserted-by":"publisher","unstructured":"Su MC, Yuan RH, Lin CY, Jeng YM (2008) Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system. Mod Pathol 21(11):1379\u20131386. https:\/\/doi.org\/10.1038\/modpathol.2008.107","DOI":"10.1038\/modpathol.2008.107"},{"issue":"5","key":"2739_CR29","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1053\/gast.2002.36598","volume":"123","author":"T Hinoi","year":"2002","unstructured":"Hinoi T, Lucas PC, Kuick R, Hanash S, Cho KR, Fearon ER (2002) CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 123(5):1565\u20131577","journal-title":"Gastroenterology"},{"issue":"6","key":"2739_CR30","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1083\/jcb.125.6.1353","volume":"125","author":"D Berndorff","year":"1994","unstructured":"Berndorff D, Gessner R, Kreft B, Schnoy N, Lajous-Petter AM, Loch N, Reutter W, Hortsch M, Tauber R (1994) Liver-intestine cadherin: molecular cloning and characterization of a novel Ca(2+)-dependent cell adhesion molecule expressed in liver and intestine. J Cell Biol 125(6):1353\u20131369","journal-title":"J Cell Biol"},{"key":"2739_CR31","doi-asserted-by":"publisher","unstructured":"Panarelli NC, Yantiss RK, Yeh MM, Liu Y, Chen YT (2012) Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2. Am J Clin Pathol 138(2):211\u2013222. https:\/\/doi.org\/10.1309\/ajcpkshxi3xehw1j","DOI":"10.1309\/ajcpkshxi3xehw1j"},{"key":"2739_CR32","doi-asserted-by":"publisher","unstructured":"Matsusaka K, Ushiku T, Urabe M, Fukuyo M, Abe H, Ishikawa S, Seto Y, Aburatani H, Hamakubo T, Kaneda A, Fukayama M (2016) Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer. Oncotarget 7(39):64168\u201364181. https:\/\/doi.org\/10.18632\/oncotarget.11638","DOI":"10.18632\/oncotarget.11638"},{"key":"2739_CR33","doi-asserted-by":"publisher","unstructured":"Talia KL, Stewart CJ, Howitt BE, Nucci MR, McCluggage WG (2017) HPV-negative gastric type adenocarcinoma in situ of the cervix: a spectrum of rare lesions exhibiting gastric and intestinal differentiation. Am J Surg Pathol 41(8):1023\u20131033. https:\/\/doi.org\/10.1097\/pas.0000000000000855","DOI":"10.1097\/pas.0000000000000855"},{"key":"2739_CR34","doi-asserted-by":"publisher","unstructured":"Park KJ, Kiyokawa T, Soslow RA, Lamb CA, Oliva E, Zivanovic O, Juretzka MM, Pirog EC (2011) Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Am J Surg Pathol 35(5):633\u2013646. https:\/\/doi.org\/10.1097\/PAS.0b013e31821534b9","DOI":"10.1097\/PAS.0b013e31821534b9"},{"key":"2739_CR35","doi-asserted-by":"publisher","unstructured":"An HJ, Kim KR, Kim IS, Kim DW, Park MH, Park IA, Suh KS, Seo EJ, Sung SH, Sohn JH, Yoon HK, Chang ED, Cho HI, Han JY, Hong SR, Ahn GH (2005) Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol 18(4):528\u2013534. https:\/\/doi.org\/10.1038\/modpathol.3800316","DOI":"10.1038\/modpathol.3800316"},{"key":"2739_CR36","doi-asserted-by":"publisher","unstructured":"Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, Richart RM, Isacson C (2000) Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 157(4):1055\u20131062. https:\/\/doi.org\/10.1016\/s0002-9440(10)64619-6","DOI":"10.1016\/s0002-9440(10)64619-6"},{"key":"2739_CR37","doi-asserted-by":"publisher","unstructured":"Carleton C, Hoang L, Sah S, Kiyokawa T, Karamurzin YS, Talia KL, Park KJ, McCluggage WG (2016) A detailed immunohistochemical analysis of a large series of cervical and vaginal gastric-type adenocarcinomas. Am J Surg Pathol 40(5):636\u2013644. https:\/\/doi.org\/10.1097\/pas.0000000000000578","DOI":"10.1097\/pas.0000000000000578"},{"key":"2739_CR38","doi-asserted-by":"publisher","unstructured":"Talia KL, Cretney A, McCluggage WG (2014) A case of HPV-negative intestinal-type endocervical adenocarcinoma in situ with coexisting multifocal intestinal and gastric metaplasia. Am J Surg Pathol 38(2):289\u2013291. https:\/\/doi.org\/10.1097\/pas.0000000000000139","DOI":"10.1097\/pas.0000000000000139"},{"issue":"1\u20132","key":"2739_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF01200733","volume":"120","author":"R Kushima","year":"1993","unstructured":"Kushima R, Hattori T (1993) Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J Cancer Res Clin Oncol 120(1\u20132):103\u2013111","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"2739_CR40","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/0046-8177(95)90219-8","volume":"26","author":"Y Fujimori","year":"1995","unstructured":"Fujimori Y, Akamatsu T, Ota H, Katsuyama T (1995) Proliferative markers in gastric carcinoma and organoid differentiation. Hum Pathol 26(7):725\u2013734","journal-title":"Hum Pathol"},{"key":"2739_CR41","doi-asserted-by":"publisher","unstructured":"Kobayashi M, Fujinaga Y, Ota H (2014) Reappraisal of the immunophenotype of pancreatic intraductal papillary mucinous neoplasms (IPMNs)-gastric pyloric and small intestinal immunophenotype expression in gastric and intestinal type IPMNs. Acta Histochem Cytochem 47(2):45\u201357. https:\/\/doi.org\/10.1267\/ahc.13027","DOI":"10.1267\/ahc.13027"},{"key":"2739_CR42","doi-asserted-by":"publisher","unstructured":"Howitt BE, Herfs M, Brister K, Oliva E, Longtine J, Hecht JL, Nucci MR (2013) Intestinal-type endocervical adenocarcinoma in situ: an immunophenotypically distinct subset of AIS affecting older women. Am J Surg Pathol 37(5):625\u2013633. https:\/\/doi.org\/10.1097\/PAS.0b013e318285be00","DOI":"10.1097\/PAS.0b013e318285be00"},{"key":"2739_CR43","doi-asserted-by":"publisher","unstructured":"Mikami Y, Hata S, Melamed J, Fujiwara K, Manabe T (2001) Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology 39(4):364\u2013372. https:\/\/doi.org\/10.1046\/j.1365-2559.2001.01239.x","DOI":"10.1046\/j.1365-2559.2001.01239.x"},{"key":"2739_CR44","doi-asserted-by":"publisher","unstructured":"Nara M, Hashi A, Murata S-I, Kondo T, Yuminamochi T, Nakazawa K, Katoh R, Hoshi K (2007) Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection. Gynecol Oncol 106(2):289\u2013298. https:\/\/doi.org\/10.1016\/j.ygyno.2007.03.044","DOI":"10.1016\/j.ygyno.2007.03.044"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02739-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-019-02739-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02739-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T21:09:13Z","timestamp":1610485753000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-019-02739-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2739"],"URL":"https:\/\/doi.org\/10.1007\/s00428-019-02739-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]},"assertion":[{"value":"18 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}